EUVIMED · CrossrefJournal
Commercial Law Review
ISSN 1226-3362 · Korean Commercial Law Association
Latest articles
A Critical Review of the Proposed Amendment to the Commercial Act to Rename “Apparent Representative Director” as “Ostensible Representative Director”
Legal consideration on the scope of subrogation by Insurers of partial insurance and limitation of liability in fire accidents - Focusing on the 2025da211931 decision of the Supreme Court on September 25, 2025 -
A Study on the Current Status of and Reform Directions for the Regulation of Quasi-Investment Advisory Business - Focusing on the Amendment to the Financial Investment Services and Capital Markets Act, Effective in August 2024 -
Securities Regulation and Investors: A Critical Review of Wealth-based Investor Classification
A Structural Analysis of the “Security Token” Regime: Distinguishing Between Distributed Ledger Adoption and Non-Standard Securities Trading
The Legal Effect of Procure Clauses in Shareholder Agreements
A Study of Warranty and Indemnity Insurance in M&A - Focusing on the notice of loss clause, scope of coverage and buyerʼs knowledge exclusion -
A Study on the Replacement of Insurance Contract
A Study on the Exclusion of Voting Rights of a Special Interested Person and Director Compensation under the Korean Commercial Act
Rethinking Director Indemnification: Liability, Defense Costs, and the Limits of Corporate Law
Interpreting the Duty of Loyalty to Shareholders under Article 382-3 of the Korean Commercial Code: A Transformative Revision Perspective with a Safe-Harbor Proposal
Preserving Standing in Shareholder Derivative Actions: Implications of Japanese Company Law
Human Driver Obligations and Personal Injury Insurance for Autonomous Vehicles in a V2SC Environment
Election Methods and Interpretative Approaches for Directors and Audit Committee Members under the 2025 Amendment to the Korean Commercial Act - Focusing on Mandatory Cumulative Voting and Separate Election of Audit Committee Members for Listed Companies with Total Assets of KRW 2 Trillion or More -
Structure and Implications of the U.S. Whistleblower Program - Focusing on the Reward System for Securities Law Violations and Accounting Fraud -
Limits on the Scope of Business Execution by Founders and Managers of Korean Private Investment Funds - Focusing on the Modification of Redeemable Convertible Preferred Share Terms -
The Introduction of a KRW-Denominated Stablecoin and the Role of the Korea Deposit Insurance Corporation
Standards for determining violation of the director’s duty of loyalty to shareholders
Review of the Contents, Limitations, and Improvements of Funding Methods under the Venture Investment Act - Focusing on Simple Agreement for Future Equity(SAFE), Convertible Note(CN), Venture Debt(VD) -
HBM Market Competition and Corporate Governance in the Age of Generative AI - Harmonizing Competition Law and Corporate Law regarding the Horizontal Shareholding Hypothesis -
A Study on the Applicability of Fraudulent Unfair Trading to the Mis-Selling of Investment Funds - Focused on Criminal Cases Arising from the Suspension of Redemptions of Lime Asset Management Private Equity Funds -
A Study on the Regulation of Major Shareholders under the Act on Corporate Governance of Financial Companies - Focusing on Financial Investment Business Entities Licensed under the Capital Markets Act -
The Development of Korean Corporate Finance Laws under the Change of Economic Situation
A Study on Legislative Direction of Business Trust
A Study on the Double Transfer of Shares and the Transfer of Title on Shareholder Registry-Korean Supreme Court 2014.4.30. 2013da99942 Judgement-
The protection of shareholders under the electronic registration system
Issuance of Redeemable Convertible Preferred Stock and Related Problems
Issuance of Sukuk under the Current Legal Regime of Corporate Finance
Prohibition against Granting Pecuniary Benefit and Revocation of shareholders` meeting`s Resolution
Why Korean Fair Trade Commission allowed the Hyundai Motors Company to merge with the Kia Motor Company during the Asian Financial Crisis?
EUVIMED